In view of the proposal by the European Commission to strengthen EU cooperation on Health Technology Assessment, the MEP Interest Group on Access will host a debate on the future of EU cooperation on HTA and its potential to improve access to innovative health technologies for patients across the EU.

By providing the platform for an exchange of views it will seek to gather the perspectives of health stakeholders before the draft report of the European Parliament is voted in ENVI. The event will take place on Tuesday, 5 June 2018 from 17:30 to 19:30 in room JAN 6Q1 in the European Parliament.

Among the distinguished speakers of the event will be Soledad Cabezón Ruiz MEP (Rapporteur in the ENVI Committee), Ioana Siska, MD, PhD (Policy Officer, Health Technology Assessment, Unit B4, DG SANTE), Ilko Getov MScPharm, PhD, (Chair of the HTA Committee to the Ministry of Health of Bulgaria), Philipp Tillich (Health Attaché, Permanent Representation of Austria to the EU)Kaisa Immonen (Director of Policy, European Patients’ Forum) and François Houÿez (Director of Treatment Information and Access, EURORDIS) as well as high-level representatives on behalf of the Austrian Ministry of Health.  

To register for the event, please click here.



No responses yet

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Our mission

    The activities of the Patient Access Partnership are patient-focused. Information and knowledge transfer are a key requirement to identify gaps in and measure access to quality healthcare between and within member states. The Partnership will develop a tool to monitor and measure equity of access in member states on an on-going basis. Through holistic collaboration with relevant EU-led or national initiatives, the Partnership will provide a much needed space for creativity, coherence and collaboration and propose sustainable solutions.

    Our vision

    The Patient Access Partnership enables different health stakeholders to join forces to develop, drive and propose to the European Commission and the European Member States sustainable solutions to ensure equitable patients’ access to quality healthcare in the EU. Stakeholders will actively participate in delivering these solutions.